Determination of the penetration of 9-fluoropropyl-(+)-dihydrotetrabenazine across the blood-brain barrier in rats by microdialysis combined with liquid chromatography-tandem mass spectrometry

被引:7
作者
Zhou, Xue [1 ]
Qiao, Jinping [1 ]
Yin, Wei [1 ]
Zhu, Lin [1 ]
Kung, Hank F. [2 ]
机构
[1] Beijing Normal Univ, Key Lab Radiopharmaceut, Coll Chem, Minist Educ, Beijing 100875, Peoples R China
[2] Univ Penn, Dept Radiol, Philadelphia, PA 19014 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2011年 / 879卷 / 28期
关键词
9-Fluoropropyl-(+)-dihydrotetrabenazine; Pharmacokinetics; Liquid chromatography-tandem mass spectrometry; Microdialysis;
D O I
10.1016/j.jchromb.2011.08.043
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To evaluate the penetration of the blood-brain barrier by 9-fluoropropyl-(+)-dihydrotetrabenazine (AV-133), microdialysis probes were implanted simultaneously into rat blood and brain, and a liquid chromatography-tandem mass spectrometric method was developed and validated to monitor the AV-133 concentration in the microdialysates. The chromatographic separation was performed on an XTerra C-18 column (150 mm x 2.1 mm id., 5 mu m particles) with gradient elution. The mass spectrometer was operated in positive mode using electrospray ionization. The analytes were measured using the multiple-reaction-monitoring mode. The calibration curves were linear over the range of 5.00-1000 ng/mLAV-133, with a coefficient of determination >0.995. The accuracies ranged from 99.5% to 105.0% and the precisions were <10% for AV-133. This method was used to determine the concentrations of AV-133 and its pharrnacokinetics in the brains and blood of rats. The blood and brain concentration-time profiles for AV-133 were obtained, and the blood-brain barrier penetration was evaluated. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3041 / 3046
页数:6
相关论文
共 19 条
  • [1] [Anonymous], 1996, INT C HARM TECHN REQ
  • [2] Rapid and precise method to locate microdialysis probe implantation in the rodent brain
    Bert, L
    Favale, D
    Jego, G
    Greve, P
    Guilloux, JP
    Guiard, BP
    Gardier, AM
    Suaud-Chagny, MF
    Lestage, P
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2004, 140 (1-2) : 53 - 57
  • [3] Giron MC, 2008, Q J NUCL MED MOL IM, V52, P254
  • [4] LC-MS/MS determination of carbamathione in microdialysis samples from rat brain and plasma
    Kaul, Swetha
    Williams, Todd D.
    Lunte, Craig E.
    Faiman, Morris D.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 51 (01) : 186 - 191
  • [5] Pharmacokinetics of [18F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain
    Kilbourn, Michael R.
    Hockley, Brian
    Lee, Lihsueh
    Hou, Catherine
    Goswami, Rajesh
    Ponde, Datta E.
    Kung, Mei-Ping
    Kung, Hank F.
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2007, 34 (03) : 233 - 237
  • [6] Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters
    Kung, Mei-Ping
    Hou, Catherine
    Goswami, Rajesh
    Ponde, Datta E.
    Kilbourn, Michael R.
    Kung, Hank F.
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2007, 34 (03) : 239 - 246
  • [7] Methods to assess tissue-specific distribution and metabolism of drugs
    Langer, O
    Müller, M
    [J]. CURRENT DRUG METABOLISM, 2004, 5 (06) : 463 - 481
  • [8] Whole-Body Biodistribution and Radiation Dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): A Novel Vesicular Monoamine Transporter 2 Imaging Agent
    Lin, Kun-Ju
    Weng, Yi-Hsin
    Wey, Shiaw-Pyng
    Hsiao, Ing-Tsung
    Lu, Chin-Song
    Skovronsky, Daniel
    Chang, Hsiu-Ping
    Kung, Mei-Ping
    Yen, Tzu-Chen
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (09) : 1480 - 1485
  • [9] Applications of LC-MS in PET Radioligand Development and Metabolic Elucidation
    Ma, Ying
    Kiesewetter, Dale O.
    Lang, Lixin
    Gu, Dongyu
    Chen, Xiaoyuan
    [J]. CURRENT DRUG METABOLISM, 2010, 11 (06) : 483 - 493
  • [10] Application of highly sensitive UPLC-MS to determine biodistribution at tracer doses: validation with the 5-HT1A ligand [18F]FPWAY
    Ma, Ying
    Lang, Lixin
    Reyes, Larry
    Tokugawa, Joji
    Jagoda, Elaine M.
    Kiesewetter, Dale O.
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2009, 36 (04) : 389 - 393